StockDuty ← Dashboard Sep 02, 2026 04:46 PM ET
SignalCorporate

Why Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report?

Earnings beat and post-report rally drove CRSP up 7.1%, signaling sustained investor optimism.

What changed
Why it matters
Earnings beat and post-report rally drove CRSP up 7.1%, signaling sustained investor optimism.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →